Acrivon Therapeutics, Inc. short interest in 2025
In 2025, Acrivon Therapeutics, Inc.'s disclosed short interest ran from 3.75% of shares outstanding on 15 Jan 2025 to 16.88% on 31 Dec 2025, a change of +13.13 percentage points. The year's high was 16.88% on 31 Dec 2025 and its low 1.79% on 29 Aug 2025, averaging 5.17% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 34.14 days on 31 Jan 2025. Full history: Acrivon Therapeutics, Inc..
Cite this page
By year: 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 3.75% (15 Jan 2025)
- End of year
- 16.88% (31 Dec 2025)
- Change
- +13.13 pp
- High
- 16.88% (31 Dec 2025)
- Low
- 1.79% (29 Aug 2025)
- Average
- 5.17%
- Highest days to cover
- 34.14 (31 Jan 2025)
- SEC filings marked
- 8
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 3.75% | 28.66 | |
| 31 Jan 2025 | 3.53% | 34.14 | |
| 14 Feb 2025 | 3.64% | 10.73 | |
| 28 Feb 2025 | 2.40% | 13.50 | |
| 14 Mar 2025 | 2.35% | 30.48 | |
| 31 Mar 2025 | 2.83% | 2.95 | results (8-K), 10-K filed |
| 15 Apr 2025 | 2.27% | 1.91 | |
| 30 Apr 2025 | 4.45% | 1.00 | |
| 15 May 2025 | 4.27% | 2.04 | 10-Q filed, results (8-K) |
| 30 May 2025 | 3.34% | 1.27 | |
| 13 Jun 2025 | 3.59% | 2.04 | |
| 30 Jun 2025 | 2.44% | 1.59 | |
| 15 Jul 2025 | 1.91% | 2.14 | |
| 31 Jul 2025 | 2.22% | 2.17 | |
| 15 Aug 2025 | 2.25% | 4.02 | 10-Q filed, results (8-K) |
| 29 Aug 2025 | 1.79% | 3.01 | |
| 15 Sep 2025 | 4.06% | 1.00 | |
| 30 Sep 2025 | 3.66% | 2.14 | |
| 15 Oct 2025 | 5.20% | 3.58 | |
| 31 Oct 2025 | 5.48% | 4.93 | |
| 14 Nov 2025 | 11.73% | 1.79 | 10-Q filed, results (8-K) |
| 28 Nov 2025 | 13.80% | 8.62 | |
| 15 Dec 2025 | 16.23% | 10.37 | |
| 31 Dec 2025 | 16.88% | 13.40 |
See also: Acrivon Therapeutics, Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.